Donate

Audio Archive

Episodes by Date

Calendar is loading...
Loading...

Be a Part of Forum

KQED BOOKS

Girl reading on a train platform. Credit: Mo Riza/Flickr

All of KQED's book coverage and author interviews in one place.

Follow us on Twitter

Twitter bird in blue

Stay updated on show topics, relevant articles, and easily submit your questions.

BOOKS THAT MATTER


KQED Books wants to know what book left its mark on you.

KQED e-Newsletters

Newsletters

Get regular updates on great programs and events

Please leave this field empty

More from KQED

Forum

Tue, Aug 28, 2012 -- 10:00 AM

Making Methuselah


Download audio (MP3)

Getty Images
Getty Images

Since the turn of the 20th century, life expectancy in the developed world has risen from just shy of 50 years to nearly 80. But how much higher can it get? Author David Ewing Duncan's new book "When I'm 164" argues that advances in medicine and bionics will drastically increase our life expectancy in the next 30 to 50 years. What are the potential social, environmental and economic ramifications of extending our lives?

Host: Michael Krasny

Guests:

  • David Ewing Duncan, author of "When I'm 164: The New Science of Radical Life Extension, and What Happens if it Succeeds," television, radio and film producer, correspondent for Atlantic.com and for public radio's Biotech Nation

More info:

David Ewing Duncan's TedxBrussel's Talk

Sponsored by

Sponsored by